EN
Contact
TeamExpertise
NewsRankings & AwardsPublications & Presentations
About usCareerContact
de|fr|it|en
DEFRIT
Contact
TeamExpertise
NewsRankings & AwardsPublications & Presentations
About usCareerContact
de|fr|it|en
DEFRIT
de|fr|it|en
Basel Bern Binningen China Desk Geneva Gstaad Japan Desk Lausanne Lugano Sion ZurichBasel Bern Binningen China Desk Geneva Gstaad Japan Desk Lausanne Lugano Sion Zurich
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Publications & Presentations
  • About us
  • Career
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Publications & Presentations
  • About us
  • Career
  • Contact
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Deals & Cases

Dr. Nicolas Mosimann
  • Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.August 27, 2026
  • Kellerhals Carrard advises on the sale of a majority stake in Hipp Technology GroupKellerhals Carrard advises on the sale of a majority stake in Hipp Technology GroupMarch 24, 2026
  • Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsKellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsMarch 11, 2026
  • Deal Ticker: Kellerhals Carrard advised on the sale of LakeraDeal Ticker: Kellerhals Carrard advised on the sale of LakeraNovember 6, 2025
  • Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsDeal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsMay 15, 2025
  • Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.Deal Ticker: Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.April 4, 2025
  • Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaKellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaDecember 3, 2024
  • Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGDeal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGMay 27, 2024
  • Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.August 23, 2023
  • Deal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker CorporationDeal Ticker: Kellerhals Carrard acted as lead counsel in connection with Biognosys’ strategic partnership with Bruker CorporationJanuary 6, 2023
  • Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.Deal Ticker: Kellerhals Carrard advised BVF on the purchase agreement with NLS Pharmaceutics.December 19, 2022
  • MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.April 6, 2022